FDA approves Genentech’s ACTPen for giant cell arteritis

Genentech has landed FDA approval for a single-dose autoinjector filled with tocilizumab (Actemra ) for patients with giant cell arteritis (GCA).
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553